Genmab A/S (GMAB)
34.15
+1.50
(+4.59%)
USD |
NASDAQ |
Sep 15, 16:00
34.15
0.00 (0.00%)
After-Hours: 20:00
Genmab Price : 34.15 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | 32.79 | 32.96 | 32.52 | 32.65 | 1.412M |
| Sep 11, 2026 | 32.45 | 32.70 | 32.27 | 32.47 | 1.394M |
| Sep 10, 2026 | 32.46 | 32.68 | 32.21 | 32.23 | 1.016M |
| Sep 09, 2026 | 33.47 | 33.75 | 32.98 | 33.04 | 2.126M |
| Sep 08, 2026 | 33.71 | 33.84 | 33.36 | 33.53 | 1.551M |
| Sep 04, 2026 | 33.96 | 34.19 | 33.54 | 33.60 | 1.003M |
| Sep 03, 2026 | 34.63 | 34.66 | 34.08 | 34.41 | 890948.0 |
| Sep 02, 2026 | 34.04 | 34.50 | 33.74 | 34.22 | 2.079M |
| Sep 01, 2026 | 33.33 | 33.67 | 33.15 | 33.29 | 1.563M |
| Aug 31, 2026 | 32.76 | 33.26 | 32.54 | 33.16 | 1.733M |
| Aug 28, 2026 | 33.78 | 33.93 | 33.12 | 33.23 | 1.519M |
| Aug 27, 2026 | 33.91 | 34.16 | 33.67 | 34.10 | 1.866M |
| Aug 26, 2026 | 33.78 | 33.90 | 33.36 | 33.75 | 3.087M |
| Aug 25, 2026 | 33.81 | 34.47 | 33.72 | 34.36 | 2.028M |
| Aug 24, 2026 | 32.82 | 33.32 | 32.74 | 33.02 | 3.247M |
| Aug 21, 2026 | 33.36 | 33.98 | 33.28 | 33.45 | 2.535M |
| Aug 20, 2026 | 33.60 | 33.77 | 33.20 | 33.41 | 6.348M |
| Aug 19, 2026 | 33.41 | 34.18 | 33.26 | 34.11 | 3.229M |
| Aug 18, 2026 | 32.86 | 33.11 | 32.66 | 32.96 | 2.707M |
| Aug 17, 2026 | 32.31 | 32.94 | 32.28 | 32.84 | 3.432M |
| Aug 14, 2026 | 31.31 | 31.98 | 31.14 | 31.94 | 3.427M |
| Aug 13, 2026 | 31.50 | 31.55 | 30.98 | 31.34 | 4.095M |
| Aug 12, 2026 | 30.69 | 31.61 | 30.69 | 31.42 | 3.517M |
| Aug 11, 2026 | 30.91 | 30.98 | 30.52 | 30.85 | 1.587M |
| Aug 10, 2026 | 30.63 | 31.01 | 30.55 | 30.87 | 2.800M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 263.00 |
| Ascendis Pharma A/S | 239.88 |
| Zealand Pharma A/S | 43.00 |
| Bavarian Nordic A/S | 10.44 |
| Evaxion AS | 3.05 |
Price Related Metrics
| PE Ratio | 27.04 |
| PS Ratio | 5.273 |
| Price to Book Value | 3.423 |
| Price to Free Cash Flow | 25.04 |
| Earnings Yield | 3.70% |
| Market Cap | 20.39B |
| Operating PE Ratio | 16.34 |
| Normalized PE Ratio | 22.16 |